Since the founding of our company, we have been developing innovative solutions for a wide range of chronic and life threatening health conditions that continue to revolutionise healthcare. We continue to be committed to developing medicines and diagnostics that improve people’s lives, delivering rapid, broad and sustainable patient access to our solutions and ultimately transforming healthcare to benefit society and people.

Focus areas

View all focus areas


Roche focuses on areas of unmet medical needs – and where we have the expertise to make a difference in improving people’s lives.

From our early days as a developer of neuropsychology, speciality antibiotics and anti-inflammatory drugs, Roche has a history of transcending conventional boundaries to deliver therapies that improve and save the lives of our customers. Our innovative approach increases the effectiveness and efficiency of the healthcare system in the diagnosis, treatment and management of acute and long-term diseases.

Roche products hold a prominent position in many major therapeutic areas, including oncology (cancer), virology, transplantation, and inflammatory and autoimmune disease. While Roche will continue to hold a strong position as a specialist healthcare provider, it is also playing an important role in the primary care arena, through medicines to treat diseases such as influenza, as well as a strong development pipeline in areas such as metabolic disorder.

The Roche Group is focused on holding its place on the world pharmaceutical stage as a leading research and development company in all areas of its business. We are committed to taking advantage of new technologies and discoveries to deliver superior quality medicines to our customers.


Roche Diagnostics has a proud tradition of innovation in healthcare around the globe. We are committed to making a real difference in people’s lives by providing products and services for the diagnosis of diseases.

Roche Diagnostics has a proud tradition of innovation in healthcare around the globe. We are committed to making a real difference in people’s lives by providing products and services for the diagnosis of diseases. One of our objectives is to develop new diagnostic tools to support healthcare professionals and patients, in their efforts to manage diseases and healthcare costs.

Our leadership in innovation is evident in our Early Infant Diagnosis of HIV program built on our globally renowned Polymerase Chain Reaction (PCR) technology. The introduction of a Dried Blood Spot (DBS) sampling option for this program has had a direct benefit for all stakeholders in the healthcare industry namely, patients, clinicians, administrators and program funders.

Roche Diagnostics’ adoption of innovation within these programs is not limited to the development of in-vitrodiagnostic assays for high burden diseases such as HIV/AIDS and TB, but also encompasses other aspects of process workflow in an effort to create sustainable solutions for the challenges posed within resource-limited regions. This is achieved through the AmpliCare Initiative, which was our proactive response to the need to expand diagnostics to these settings.

We are committed to capacity building initiatives through ongoing certified training of laboratory scientists at the Roche PCR Academy in Johannesburg, to ensure highest results, quality and reliability. This training includes education of Health Care Professionals on molecular theory and techniques enabling them to deliver better patient management outcomes.

Through Roche’s research and development initiatives, we also apply our expertise to develop novel solutions, precise and robust diagnostic tests, automated systems and integrated solutions in the fields of Clinical Chemistry, Haematology, Coagulation and Immunodiagnostics.

We believe that through continued effort and investment in the latest innovations in diagnostics, Roche can make a positive, sustainable and cost-effective contribution to developing world healthcare.

Roche Diagnostics is the world leader in in vitro diagnostics. Roche Diagnostics offers a uniquely broad product portfolio and supplies a wide array of innovative testing products and services to researchers, physicians, patients, hospitals and laboratories in the fields of diabetes care and anticoagulation therapy, molecular biology, clinical chemistry, immunology and applied science.

Our portfolio includes:

  • Blood glucose meters for people with diabetes

  • Point-of-care testing devices for use in doctors’ offices

  • High-throughput analysers for hospitals and commercial diagnostic laboratories

  • State-of-the-art instruments and reagents for life science research

Discover more

Access Product Information

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.

ContactLocationslinkedinfacebooktwitterinstagramyoutubeAbout RochePersonalised healthcareStoriesMedia releasesRoche careersRoche Pharma Privacy PolicyDiagnostics Privacy PolicyCookie Policy